Home

Sensabues AB offers a novel device and method to detect non-volatile substances in blood by collecting an exhaled breath biological sample for lab-based analysis.

This method detects a wide range of exogenous substances, such as:

performance enhancing drugs (e.g. stimulants and anabolic agents) in sports.

(e.g. stimulants and anabolic agents) in sports. drugs of abuse ( e.g. cannabinoids and narcotics).

e.g. cannabinoids and narcotics). therapeutic drugs (e.g. antibiotics and glucocorticoids).

A wide range of endogenous substances, associated with the study of metabolomics and determination of biomarkers, can be detected also.

Using the existing installed base of laboratory instrumentation already being utilised by other matrices, together with established and validated analytical procedures, this exhaled breath-based biomatrix platform called ExaBreath® (EB), is transforming drug detection, health monitoring and medical diagnostics for:

anti-doping/performance enhancing drugs control in sport

drug prevention programs in sports

drugs of abuse testing

therapeutic drug monitoring

biomarker detection

metabolomics analysis

EB achieves this by:

lowering the overall cost of sample collection

reducing sample collection time and complexity

improving the accuracy and correlation of testing

detecting parent/intact drugs as well as their metabolites

making sample collection more convenient and less intrusive

increasing the acceptability and frequency of sample collection

affording more protection for a donor’s right-to-privacy

enabling new types of collection procedures

EB has detected over 80 substances across these categories: